Home >  News >  July, 2014

Tainted Lot of Marcaine Recalled by Hospira

Customer noticed particulate in the solution.

Published: July 1, 2014

A recall of one lot of Marcaine (bupivacaine) has been initiated by Hospira, after a customer reported seeing particulate embedded in a glass vial and in the solution.

The affected lot (0.5% Marcaine [Bupivacaine HCl Injection, USP], 30 mL, Single-dose Vial — Preservative Free [NDC 0409-1560-29], Lot 33-545-DD) was distributed between November 2013 and March 2014 to wholesalers/distributors, hospitals and clinics nationwide.

If the particulate is administered to a patient, it could block administration and cause a delay in therapy. However, the identified particulate is so small, it's more likely to pass through the catheter and cause inflammation, mechanical disruption of tissue or immune response, says the company. There's also an extremely unlikely possibility that if exposed to a strong magnetic field, such as an MRI, the particulate could dislodge and cause tissue damage.

Hospira says it hasn't received any reports of adverse effects associated with the lot, and that the problem is the result of a supplier's glass defect.

The affected product should immediately be pulled and quarantined, says Hospira, which is issuing recall letters to customers and distributors and arranging for it to be returned to Stericycle, which can be reached at 1-888-656-6380.

Jim Burger


Also in the News...

Senate Finance Committee Takes Aim at Concurrent and Overlapping Surgeries
Negligence Complaint Ties Lung Paralysis to Improper Placement of Regional Block
Surgeons Remove Thyroid Gland by Making 3 Small Incisions Inside the Mouth Underneath Lower Lip
Anesthesiologist Dealing with Fallout Following Racially Insensitive Facebook Post About First Lady
Bill Promotes Pricing Transparency and Protects Physicians From EHR Penalties
Donald Trump Picks Staunch Obamacare Critic Tom Price, MD, as U.S. Secretary of Health and Human Services
Appendectomy Patients Don't Need an Overnight Stay

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

No Excuses for Mistaken Patient Identity

Researchers: Pregabalin Linked to Birth Defects

European study raises red flag on multimodal drug's use among childbearing women.

Make Sure Your Pre-Surgical Checklists Are Followed